Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ayahuasca vs Esketamine for PTSD
NCT07317206Phase 2Recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ayahuasca in post-traumatic stress disorder (PTSD), sponsored by Universidade de São Paulo. Started Dec 2025; status: recruiting.
02
Drugs
ayahuasca
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07317206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07317206.